Invention Grant
- Patent Title: 2,5-disubstituted arylsulfonamide CCR3 antagonists
- Patent Title (中): 2,5-二取代芳基磺酰胺CCR3拮抗剂
-
Application No.: US12764900Application Date: 2010-04-21
-
Publication No.: US08399456B2Publication Date: 2013-03-19
- Inventor: Tai Wei Ly , Marie Chantal Siu-Ying Tran , Erik Dean Raaum
- Applicant: Tai Wei Ly , Marie Chantal Siu-Ying Tran , Erik Dean Raaum
- Applicant Address: US CA San Diego
- Assignee: Axikin Pharmaceuticals, Inc.
- Current Assignee: Axikin Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: A61K31/551
- IPC: A61K31/551 ; A61K31/445 ; A61K31/495 ; A61K31/5375 ; A61K31/4468 ; A61K31/454 ; A61K31/277 ; C07D211/58 ; C07D295/14 ; C07D243/08 ; C07D401/04 ; C07D487/04
Abstract:
Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
Public/Granted literature
- US20100273782A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS Public/Granted day:2010-10-28
Information query
